Sabra Health Care REIT, Inc.
General ticker "SBRA" information:
- Sector: Real Estate
- Industry: REIT - Healthcare Facilities
- Capitalization: $4.7B (TTM average)
Sabra Health Care REIT, Inc. follows the US Stock Market performance with the rate: 18.0%.
Estimated limits based on current volatility of 1.7%: low 18.29$, high 18.93$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-05-15, amount 0.30$ (Y6.65%)
- Total employees count: 50 as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Labor/talent shortage/retention, Pandemic risks, Regulatory and compliance, Market competition, Occupancy rates
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [16.24$, 20.65$]
- 2026-12-31 to 2027-12-31 estimated range: [16.41$, 20.94$]
Financial Metrics affecting the SBRA estimates:
- Positive: with PPE of 12.4 at the end of fiscal year the price was neutral
- Positive: 6.59 < Operating cash flow per share per price, % of 7.70
- Positive: Operating profit margin, % of 34.06 > 18.39
- Positive: 42.59 < Shareholder equity ratio, % of 51.37 <= 64.29
- Negative: Investing cash flow per share per price, % of -8.34 <= -4.41
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 2.75
- Negative: -0.16 < Industry inventory ratio change (median), % of 0
- Positive: Interest expense per share per price, % of 2.48 <= 3.31
- Positive: Industry operating profit margin (median), % of 14.17 > 9.60
Short-term SBRA quotes
Long-term SBRA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $647.51MM | $703.24MM | $774.63MM |
| Operating Expenses | $425.80MM | $446.21MM | $510.76MM |
| Operating Income | $221.71MM | $257.03MM | $263.87MM |
| Non-Operating Income | $-205.95MM | $-129.31MM | $-106.52MM |
| Interest Expense | $112.96MM | $115.27MM | $112.49MM |
| Income(Loss) | $15.76MM | $127.72MM | $157.35MM |
| Taxes | $2.00MM | $1.00MM | $1.84MM |
| Net Income(Loss)* | $13.76MM | $126.71MM | $155.61MM |
| Stockholders Equity | $2,802.53MM | $2,741.29MM | $2,821.84MM |
| Assets | $5,386.15MM | $5,303.68MM | $5,493.40MM |
| Operating Cash Flow | $300.57MM | $310.54MM | $348.61MM |
| Investing Cash Flow | $103.13MM | $-109.00MM | $-377.96MM |
| Financing Cash Flow | $-410.30MM | $-181.56MM | $40.76MM |
| Earnings Per Share** | $0.06 | $0.54 | $0.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.